Treatment Outcome of Adult Burkitt Lymphoma in Japanese Patients with Modified LMB Protocol : A Single Center Retrospective Analysis
スポンサーリンク
概要
- 論文の詳細を見る
The prognosis of adult Burkitt lymphoma (BL) has improved in western countries since the introduction of high-dose methotrexate (HD-MTX)-containing chemotherapy. Here we analyzed nine consecutive Japanese patients diagnosed with BL at our institution. All except for the three elderly (> 70 years) patients were treated with a regimen including 13 g/m2 HD-MTX in total, divided into 3 cycles. The median follow-up period was 56 months (range 38-118). All the nine patients achieved complete remission and have not shown any disease progression, including the three elderly patients who received reduced doses or alternative treatments. These observations suggest that chemotherapy including 13 g/m2 HD-MTX in total is tolerable and effective in Japanese adult BL patients aged < 70 and that BL is curable even if developed in those who are > 70 years. [J Clin Exp Hematopathol 51(2) : 109-114, 2011]
論文 | ランダム
- P628 運動開始時の呼気ガス諸指標の時定数におよぼす負荷量の影響について
- 心不全の治療目的 : 心機能改善は期待出来るか?
- 22) うっ血性心不全の長期予後 : 日本循環器会第57回北陸地方会
- 164)MR imageによる大血管疾患の診断 : 日本循環器学会第68回東海・第53回北陸合同地方会
- 163)心筋梗塞症のNMR Image第2報 : 日本循環器学会第68回東海・第53回北陸合同地方会